Altre lingue Immunocore Holdings plc

Azioni

IMCR

US45258D1054

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 24/04/2024			Variaz. 5gg	Var. 1 gen.
58,47 ^USD	+2,02%		+7,13%	-14,42%

21/03	Immunocore Holdings deposita una registrazione Shelf con titoli misti	MT
14/03	Transcript : Immunocore Holdings plc Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-14-2024 09:30 AM

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Immunocore announces upcoming presentation and posters at ASCO 2024	24/04
Immunocore to present at upcoming investor conferences	04/04
Immunocore Holdings Files Mixed-Securities Shelf Registration	21/03
Immunocore presented two posters at CROI 2024	05/03
Immunocore to present at upcoming investor conferences	01/03
Immunocore Holdings' Q4 Net Loss Narrows, Revenue Rises	28/02
Earnings Flash (IMCR) IMMUNOCORE HOLDINGS LIMITED Reports Q4 Revenue $70.2M, vs. Street Est of $68.5M	28/02
Immunocore reports fourth quarter and full year 2023 financial results and provides a business update	28/02
Immunocore Holdings plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/02
Immunocore Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Immunocore Collaborates With Bristol Myers Squibb in Advanced Cutaneous Melanoma Trial	22/02
Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to evaluate IMC-F106C (PRAME HLA-A02) in combination with nivolumab in its registrational Phase 3 first-line advanced cutaneous melanoma trial	22/02
Immunocore to report fourth quarter and full year 2023 financial results and host call on February 28, 2024	21/02
Immunocore Prices Upsized $350 Million Convertible Notes Offering	31/01
Immunocore Prices Upsized Convertible Senior Notes Offering	31/01
Immunocore Prices Upsized Convertible Senior Notes Offering	31/01
Sector Update: Health Care Stocks Lean Lower Premarket Tuesday	30/01
Immunocore Plans $300 Million Convertible Senior Notes Offering ; Shares Fall After-Hours	29/01
Immunocore Holdings plc Provides Preliminary Unaudited Revenue Guidance for the Fourth Quarter and Full Year 2023	29/01
Immunocore Announces Proposed Convertible Senior Notes Offering	29/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Immunocore Holdings plc

Azioni

IMCR

US45258D1054

Altre lingue

Filtri